Medical devices and equipmentStudy leads to insulin injection recommendations | Reuters
Many people who inject themselves with insulin to control diabetes are improperly performing this vital task, according to a new large study. Based on the results, experts have crafted recommendations for people who use insulin that touch on everything from what type of needle to use to where the shot should be administered.
PharmaceuticalsIn wake of Mylan controversy, Clinton proposes oversight group for sudden drug price hikes | Morning Consult
Hillary Clinton on Friday updated her plans to lower prescription drug costs, this time focusing on “unjustified price hikes” to pharmaceuticals that have long been on the market.
The journal Nature published intriguing results for an experimental Alzheimer's drug called aducanumab, which is manufactured by Cambridge, Mass.-based Biogen. The treatment appeared to reduce the build-up of amyloid plaque in patients, delaying their physical and mental deterioration.
Takeda Vaccines of Deerfield, Ill., announced Thursday it will pursue development of a Zika vaccine with funding from the Biomedical Advanced Research and Development Authority, a division of the HHS that spurs development of drugs, vaccines and diagnostic tests needed to respond to or prepare for health emergencies.
AstraZeneca and Glaxo are studying therapies that reduce eosinophil levels to see whether they can change the trajectory of respiratory disease, similar to cholesterol-cutting stains prescribed to prevent heart attacks.
Safety, quality and clinical practiceWhat happens when a living kidney donor needs a transplant? | Kaiser Health News
Living kidney donors who are in need of a transplant have, since 1996, been given priority status to shorten their time on the waiting list. But according to a study published Thursday in the Clinical Journal of the American Society of Nephrology, prior living donors don't always receive the priority status in a timely manner.